Selected article for: "acute phase and lung diffusion capacity"
Author: Shah, Aditi S; Wong, Alyson W; Hague, Cameron J; Murphy, Darra T; Johnston, James C; Ryerson, Christopher J; Carlsten, Christopher
Title: A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations
  • Cord-id: ni93ii3n
  • Document date: 2020_12_3
    • ID: ni93ii3n
    Snippet: The long-term respiratory morbidity of COVID-19 remains unclear. We describe the clinical, radiological and pulmonary function abnormalities that persist in previously hospitalised patients assessed 12 weeks after COVID-19 symptom onset, and identify clinical predictors of respiratory outcomes. At least one pulmonary function variable was abnormal in 58% of patients and 88% had abnormal imaging on chest CT. There was strong association between days on oxygen supplementation during the acute phas
    Document: The long-term respiratory morbidity of COVID-19 remains unclear. We describe the clinical, radiological and pulmonary function abnormalities that persist in previously hospitalised patients assessed 12 weeks after COVID-19 symptom onset, and identify clinical predictors of respiratory outcomes. At least one pulmonary function variable was abnormal in 58% of patients and 88% had abnormal imaging on chest CT. There was strong association between days on oxygen supplementation during the acute phase of COVID-19 and both DLCO-% (diffusion capacity of the lung for carbon monoxide) predicted and total CT score. These findings highlight the need to develop treatment strategies and the importance of long-term respiratory follow-up after hospitalisation for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • abnormal dlco and lung capacity: 1, 2
    • abnormal dlco and lung function: 1, 2
    • acute phase and long term consequence: 1, 2, 3
    • acute phase and longitudinal assessment: 1, 2
    • acute phase and lung capacity: 1, 2, 3, 4, 5, 6, 7
    • acute phase and lung diffusion capacity: 1, 2
    • acute phase and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute phase and lung percentage: 1
    • acute phase and lung volume: 1, 2, 3, 4, 5, 6
    • long term consequence and lung capacity: 1
    • long term consequence and lung function: 1
    • long term respiratory outcome and lung function: 1